Rinvoq is now approved for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 years old and older whose disease did not respond to previous treatment.
In the second part of the series, DSN editor in chief Nigel Maynard continues his discussion with eight young women to find out if cost and the availability of medical services have influenced how they visit retail pharmacies.